Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$26,106,832
+$5,394,041 QoQ
Shares Held
498,222
-14.9% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#56
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (42.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
498,222 | $26,106,832 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
64,908 | $10,939,594 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
71,901 | $4,598,068 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
240,060 | $4,155,438 | |
| 5 | LQDA |
Liquidia Corp
|
50,802 | $4,050,443 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
32,860 | $2,720,150 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
408,064 | $1,717,949 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,931 | $1,206,050 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,106,832 | 498,222 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,712,791 | 585,769 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $17,215,870 | 615,292 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,894,370 | 596,479 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,992,566 | 593,938 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,461,669 | 528,821 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $16,382,271 | 569,620 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $33,114,969 | 1,183,100 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $29,424,533 | 1,220,935 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,302,354 | 1,082,466 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $30,521,018 | 1,100,253 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,762,643 | 991,169 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $30,755,912 | 982,617 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $27,868,267 | 988,587 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,358,570 | 511,235 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,951,744 | 445,667 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,841,307 | 431,061 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,321,087 | 430,296 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,968,724 | 428,578 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,661,269 | 410,547 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $9,865,597 | 402,349 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,524,173 | 402,793 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,052,498 | 403,634 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $4,249,470 | 218,932 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,062,507 | 143,031 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||